Marta Rysz

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Magnetic Resonance

Epidermal Growth Factor Receptor

Top Venues

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, Jonny Kinzi, Karin Brecht, Isabell Seibert, Seraina Schmidlin, Katja In-Albon, Daniel Ricklin, Henriette E Meyer Zu Schwabedissen
Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)